Current and Future Therapies for Hepatitis C Virus Infection

被引：345

作者：

Liang, T. Jake ^{[1
]}

Ghany, Marc G. ^{[1
]}

机构：

[1] NIDDKD, Liver Dis Branch, NIH, Bethesda, MD 20892 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2013年 / 368卷 / 20期

关键词：

SUSTAINED VIROLOGICAL RESPONSE; PROTEASE INHIBITOR; TREATMENT-NAIVE; PLUS RIBAVIRIN; VIRAL LOAD; BOCEPREVIR; TELAPREVIR; COMBINATION; RESISTANCE; SOFOSBUVIR;

D O I：

10.1056/NEJMra1213651

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1907 / 1917

页数：11

共 72 条

[1] Hepatitis C Pharmacogenetics: State of the Art in 2010 [J].

Afdhal, Nezam H. ;

McHutchison, John G. ;

Zeuzem, Stefan ;

Mangia, Alessandra ;

Pawlotsky, Jean-Michel ;

Murray, Jeffrey S. ;

Shianna, Kevin V. ;

Tanaka, Yasuhito ;

Thomas, David L. ;

Booth, David R. ;

Goldstein, David B. .

HEPATOLOGY, 2011, 53 (01) :336-345

[2] Hepatitis c virus and host cell lipids An intimate connection [J].

Alvisi, Gualtiero ;

Madan, Vanesa ;

Bartenschlager, Ralf .

RNA BIOLOGY, 2011, 8 (02) :258-269

[3] Characterization of low- and very-low-density hepatitis C virus RNA-containing particles [J].

André, P ;

Komurian-Pradel, F ;

Deforges, S ;

Perret, M ;

Berland, JL ;

Sodoyer, M ;

Pol, S ;

Bréchot, C ;

Paranhos-Baccalà, G ;

Lotteau, V .

JOURNAL OF VIROLOGY, 2002, 76 (14) :6919-6928

[4] National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002 - June 10-12, 2002 [J].

不详 .

HEPATOLOGY, 2002, 36 (05) :S3-S20

[5] A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C [J].

Backus, Lisa I. ;

Boothroyd, Derek B. ;

Phillips, Barbara R. ;

Belperio, Pamela ;

Halloran, James ;

Mole, Larry A. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (06) :509-U145

[6] Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection [J].

Bacon, Bruce R. ;

Gordon, Stuart C. ;

Lawitz, Eric ;

Marcellin, Patrick ;

Vierling, John M. ;

Zeuzem, Stefan ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Boparai, Navdeep ;

Burroughs, Margaret ;

Brass, Clifford A. ;

Albrecht, Janice K. ;

Esteban, Rafael .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) :1207-1217

[7] SUSTAINED VIROLOGIC RESPONSE (SVR) IN PRIOR PEGINTERFERON/RIBAVIRIN (PR) TREATMENT FAILURES AFTER RETREATMENT WITH BOCEPREVIR (BOC)-+-PR: THE PROVIDE STUDY INTERIM RESULTS [J].

Bronowicki, J. P. ;

Davis, M. ;

Flamm, S. ;

Gordon, S. ;

Lawitz, E. ;

Yoshida, E. ;

Galati, J. ;

Luketic, V. ;

McCone, J. ;

Jabobson, I. ;

Marcellin, P. ;

Muir, A. ;

Poordad, F. ;

Pedicone, L. D. ;

Deng, W. ;

Treitel, M. ;

Wahl, J. ;

Vierling, J. .

JOURNAL OF HEPATOLOGY, 2012, 56 :S6-S6

[8] Hepatitis C and liver transplantation [J].

Brown, RS .

NATURE, 2005, 436 (7053) :973-978

[9] Sustained Virologic Response Prevents the Development of Esophageal Varices in Compensated, Child-Pugh Class A Hepatitis C Virus-Induced Cirrhosis. A 12-Year Prospective Follow-up Study [J].

Bruno, Savino ;

Crosignani, Andrea ;

Facciotto, Corinna ;

Rossi, Sonia ;

Roffi, Luigi ;

Redaelli, Alessandro ;

de Franchis, Roberto ;

Almasio, Piero Luigi ;

Maisonneuve, Patrick .

HEPATOLOGY, 2010, 51 (06) :2069-2076

[10] Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders [J].

Chayama, Kazuaki ;

Takahashi, Shoichi ;

Toyota, Joji ;

Karino, Yoshiyasu ;

Ikeda, Kenji ;

Ishikawa, Hiroki ;

Watanabe, Hideaki ;

McPhee, Fiona ;

Hughes, Eric ;

Kumada, Hiromitsu .

HEPATOLOGY, 2012, 55 (03) :742-748

← 1 2 3 4 5 6 7 8 →